OpenURL Connection Search

Select item for more details and to access through your institution.

Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18760-1
By:
- Goedken, Eric R.;
- Argiriadi, Maria A.;
- Dietrich, Justin D.;
- Petros, Andrew M.;
- Krishnan, Navasona;
- Panchal, Sanjay C.;
- Qiu, Wei;
- Wu, Haihong;
- Zhu, Haizhong;
- Adams, Ashley M.;
- Bodelle, Pierre M.;
- Goguen, Lucas;
- Richardson, Paul L.;
- Slivka, Peter F.;
- Srikumaran, Myron;
- Upadhyay, Anup K.;
- Wu, Bainan;
- Judge, Russell A.;
- Vasudevan, Anil;
- Gopalakrishnan, Sujatha M.
Publication type:
Article
Discovery and Design of Novel HSP90 Inhibitors Using Multiple Fragment-based Design Strategies.
Published in:
Chemical Biology & Drug Design, 2007, v. 70, n. 1, p. 1, doi. 10.1111/j.1747-0285.2007.00535.x
By:
- Huth, Jeffrey R.;
- Chang Park;
- Petros, Andrew M.;
- Kunzer, Aaron R.;
- Wendt, Michael D.;
- Xilu Wang;
- Lynch, Christopher L.;
- Mack, Jamey C.;
- Swift, Kerry M.;
- Judge, Russell A.;
- Jun Chen;
- Richardson, Paul L.;
- Sha Jin;
- Tahir, Stephen K.;
- Matayoshi, Edward D.;
- Dorwin, Sarah A.;
- Ladror, Uri S.;
- Severin, Jean M.;
- Walter, Karl A.;
- Bartley, Diane M.
Publication type:
Article
Efficiently driving protein-based fragment screening and lead discovery using two-dimensional NMR.
Published in:
Journal of Biomolecular NMR, 2023, v. 77, n. 1/2, p. 39, doi. 10.1007/s10858-022-00410-3
By:
- Peng, Chen;
- Namanja, Andrew T.;
- Munoz, Eva;
- Wu, Haihong;
- Frederick, Thomas E.;
- Maestre-Martinez, Mitcheell;
- Iglesias Fernandez, Isaac;
- Sun, Qi;
- Cobas, Carlos;
- Sun, Chaohong;
- Petros, Andrew M.
Publication type:
Article
NMR-based fragment screening and lead discovery accelerated by principal component analysis.
Published in:
Journal of Biomolecular NMR, 2019, v. 73, n. 12, p. 675, doi. 10.1007/s10858-019-00279-9
By:
- Namanja, Andrew T.;
- Xu, Jia;
- Wu, Haihong;
- Sun, Qi;
- Upadhyay, Anup K.;
- Sun, Chaohong;
- Van Doren, Steven R.;
- Petros, Andrew M.
Publication type:
Article
1H,13C and15N Resonance Assignments of a Bcl-xL/Bad Peptide Complex.
Published in:
Journal of Biomolecular NMR, 2005, v. 32, n. 3, p. 260, doi. 10.1007/s10858-005-7957-1
By:
- Petros, Andrew M.;
- Fesik, Stephen W.;
- Olejniczak, Edward T.
Publication type:
Article
Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins.
Published in:
Oncogene, 2004, v. 23, n. 3, p. 835, doi. 10.1038/sj.onc.1207141
By:
- Joseph, Mary K.;
- Solomon, Larry R.;
- Petros, Andrew M.;
- Cai, Jill;
- Simmer, Robert L.;
- Zhang, Haichao;
- Rosenberg, Saul;
- Shi-Chung Ng
Publication type:
Article
A Surface Groove Essential for Viral Bcl-2 Function During Chronic Infection In Vivo.
Published in:
PLoS Pathogens, 2005, v. 1, n. 1, p. 80, doi. 10.1371/journal.ppat.0010010
By:
- Loh, Joy;
- Qiulong Huang;
- Petros, Andrew M.;
- Nettesheim, David;
- Van Dyk, Linda F.;
- Labrada, Lucia;
- Speck, Samuel H.;
- Levine, Beth;
- Olejniczak, Edward T.;
- Virgin IV, Herbert W.;
- McFadden, Grant
Publication type:
Article
Fragment-based lead discovery: challenges and opportunities.
Published in:
Journal of Computer-Aided Molecular Design, 2011, v. 25, n. 7, p. 607, doi. 10.1007/s10822-011-9451-z
By:
- Chaohong Sun;
- Petros, Andrew M.;
- Hajduk, Philip J.
Publication type:
Article
Ligand binding to domain-3 of human serum albumin: a chemometric analysis.
Published in:
Journal of Computer-Aided Molecular Design, 2003, v. 17, n. 2-4, p. 93, doi. 10.1023/A:1025305520585
By:
- Hajduk, Philip J.;
- Mendoza, Renaldo;
- Petros, Andrew M.;
- Huth, Jeffrey R.;
- Bures, Mark;
- Fesik, Stephen W.;
- Martin, Yvonne C.
Publication type:
Article
Defining the p53 DNA-binding domain/Bcl-xL-binding interface using NMR
Published in:
FEBS Letters, 2004, v. 559, n. 1-3, p. 171, doi. 10.1016/S0014-5793(04)00059-6
By:
- Petros, Andrew M.;
- Gunasekera, Angelo;
- Xu, Nan;
- Olejniczak, Edward T.;
- Fesik, Stephen W.
Publication type:
Article
Rationale for Bcl-XL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
Published in:
Protein Science: A Publication of the Protein Society, 2000, v. 9, n. 12, p. 2528, doi. 10.1110/ps.9.12.2528
By:
- Petros, Andrew M.;
- Nettesheim, David G.;
- Wang, Yi;
- Olejniczak, Edward T.;
- Meadows, Robert P.;
- Mack, Jamey;
- Swift, Kerry;
- Matayoshi, Edmund D.;
- Zhang, Haichao;
- Fesik, Stephen W.;
- Thompson, Craig B.
Publication type:
Article
Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
Published in:
Nature, 1995, v. 378, n. 6557, p. 584, doi. 10.1038/378584a0
By:
- Zhou, Ming-Ming;
- Petros, Andrew M.
Publication type:
Article

Found: 12

Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site.

Discovery and Design of Novel HSP90 Inhibitors Using Multiple Fragment-based Design Strategies.

Efficiently driving protein-based fragment screening and lead discovery using two-dimensional NMR.

NMR-based fragment screening and lead discovery accelerated by principal component analysis.

<sup>1</sup>H,<sup>13</sup>C and<sup>15</sup>N Resonance Assignments of a Bcl-xL/Bad Peptide Complex.

Divergence of Genbank and human tumor Bcl-2 sequences and implications for binding affinity to key apoptotic proteins.

A Surface Groove Essential for Viral Bcl-2 Function During Chronic Infection In Vivo.

Fragment-based lead discovery: challenges and opportunities.

Ligand binding to domain-3 of human serum albumin: a chemometric analysis.

Defining the p53 DNA-binding domain/Bcl-x<sub>L</sub>-binding interface using NMR

Rationale for Bcl-X<sub>L</sub>/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Structure and ligand recognition of the phosphotyrosine binding domain of Shc.